IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through the sale of roughly 625,000 units.
在以色列和德國開展業務的醫療大麻公司，Im Cannabis 業務股（NASDAQ:IMCC）（CSE:IMCC），計劃通過銷售約625,000份單位的定向增發，最多籌集1,613,000美元。
What Happened: Each unit will be comprised of one share and one share purchase warrant, with each warrant entitling the holder to acquire one additional share at a price equal to a 50% premium to the offering price before the second anniversary of the closing date.
事件簡介：每個單位將由一股和一個認股權證組成，每個認股權證使持有人有權在結束日前第二個週年以50%的溢價價格購買一股額外股票。
The company plans to close the offering in one or more tranches. It will be led by the company's management team, including Oren Shuster, CEO and chairman of the board of directors and Shmulik Arbel, a director of the company.
該公司計劃分多筆或一次性關閉本次定向增發。這將由公司的管理團隊領導，包括董事會董事長兼CEO Oren Shuster以及董事Shmulik Arbel。
Why It Matters: The company intends to use the proceeds from the offering for the repayment of a loan to A.D.I. CAR ALARMS & STEREO SYSTEMS Ltd. provided to the company's subsidiary IMC Holdings Ltd. on Oct. 11, 2022.
爲何重要：公司打算使用本次定向增發的收益償還於2022年10月11日向公司子公司IMC Holdings Ltd.提供的貸款給A.D.I. CAR ALARMS & STEREO SYSTEMS Ltd。
What's Next: The closing of the offering is expected to occur by Nov. 11, 2024.
下一步怎麼辦：預計本次定向增發將於2024年11月11日完成。
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
- 獲取Benzinga獨家分析和有關大麻股行業和市場的頭條資訊，每天免費發送至您的收件箱。在此訂閱我們的新聞簡訊。如果您認真對待業務，您不能錯過。
Recent Moves
最近的動向
The company announced a major share consolidation plan in July. Its board of directors approved a consolidation of its issued and outstanding common shares under which every six pre-consolidated common shares will convert into one post-consolidated share.
該公司於7月宣佈了一項重大股份合併計劃。其董事會批准了一項發行和流通普通股的合併，根據該合併，每六股合併前的普通股將轉爲一股合併後的股。
The strategic decision reduced its outstanding shares from 13,394,136 to 2,232,357, making the stock more attractive to institutional investors and improving liquidity.
這一戰略決定將其未流通股份從13,394,136股減少到2,232,357股，使得該股票更受機構投資者青睞，並提高了流動性。
Read Also: IM Cannabis Shares Surge 586% After 6:1 Consolidation: What Investors Need To Know
閱讀更多：大麻股合併後暴漲586%：投資者需要了解的事項
The company's second quarter financial results reported in August revealed a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The company also reported a 129% year-over-year increase in IMC German sales to CA$3.5 million, making up 24% of the entire company revenue.
該公司於8月公佈的第二季度財務業績顯示，營業收入同比增長12%，達到1480萬加元（1080萬美元），該公司還報告稱，IMC德國銷售同比增長129%，達到350萬加元，佔整個公司營業收入的24%。
The company reported on Wednesday the preliminary sales results in Germany by its subsidiary operating in the country, Adjupharm GmbH, for the third quarter of 2024. The results have significantly exceeded expectations, the medical cannabis company with operations in Israel and Germany said, reporting a 50% increase in revenue compared to the previous quarter.
該公司報告稱，週三通過在德國運營的子公司Adjupharm GmbH公佈了2024年第三季度初步銷售業績。該結果顯著超出預期，這家在以色列和德國開展業務的醫用大麻公司表示，與上一季度相比，營業收入增長了50%。
IMCC's shares were trading 3.15% higher at $2.2899 per share at the time of the writing on Friday.
IMCC的股票在週五寫作時以2.2899美元的價格每股上漲了3.15%。
- IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
- 大麻股飆升：德國銷量在合法化後的前3個月激增200%，第二季度營收同比增長12%
譯文內容由第三人軟體翻譯。
